These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37299207)

  • 21. Self-assembled peptide nanorod vaccine confers protection against influenza A virus.
    Zottig X; Al-Halifa S; Côté-Cyr M; Calzas C; Le Goffic R; Chevalier C; Archambault D; Bourgault S
    Biomaterials; 2021 Feb; 269():120672. PubMed ID: 33476893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.
    Yong CY; Yeap SK; Ho KL; Omar AR; Tan WS
    Int J Nanomedicine; 2015; 10():2751-63. PubMed ID: 25897220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
    Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
    Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Immunogenicity of M2e Peptide of Avian Influenza Virus H5N1 Fused to Ricin Toxin B Chain Produced in Duckweed Plants.
    Firsov A; Tarasenko I; Mitiouchkina T; Shaloiko L; Kozlov O; Vinokurov L; Rasskazova E; Murashev A; Vainstein A; Dolgov S
    Front Chem; 2018; 6():22. PubMed ID: 29487846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
    Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
    Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
    De Filette M; Fiers W; Martens W; Birkett A; Ramne A; Löwenadler B; Lycke N; Jou WM; Saelens X
    Vaccine; 2006 Nov; 24(44-46):6597-601. PubMed ID: 16814430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant-produced Recombinant Influenza A Vaccines Based on the M2e Peptide.
    Mardanova ES; Ravin NV
    Curr Pharm Des; 2018; 24(12):1317-1324. PubMed ID: 29521217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
    Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y
    Virol J; 2010 Jul; 7():151. PubMed ID: 20624292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.
    Ma JH; Yang FR; Yu H; Zhou YJ; Li GX; Huang M; Wen F; Tong G
    Virol J; 2013 Jul; 10():227. PubMed ID: 23834899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel M2e based flu vaccine formulation for dogs.
    Leclerc D; Rivest M; Babin C; López-Macias C; Savard P
    PLoS One; 2013; 8(10):e77084. PubMed ID: 24098576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.
    Denis J; Acosta-Ramirez E; Zhao Y; Hamelin ME; Koukavica I; Baz M; Abed Y; Savard C; Pare C; Lopez Macias C; Boivin G; Leclerc D
    Vaccine; 2008 Jun; 26(27-28):3395-403. PubMed ID: 18511159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.
    Carignan D; Thérien A; Rioux G; Paquet G; Gagné ML; Bolduc M; Savard P; Leclerc D
    Vaccine; 2015 Dec; 33(51):7245-7253. PubMed ID: 26549362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X.
    Mardanova ES; Blokhina EA; Tsybalova LM; Peyret H; Lomonossoff GP; Ravin NV
    Front Plant Sci; 2017; 8():247. PubMed ID: 28293244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    Bimler L; Ronzulli SL; Song AY; Johnson SK; Jones CA; Kim T; Le DT; Tompkins SM; Paust S
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33268521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge.
    Mezhenskaya D; Isakova-Sivak I; Matyushenko V; Donina S; Rekstin A; Sivak K; Yakovlev K; Katelnikova A; Kryshen K; Makarov V; Rudenko L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70(359-610) in prokaryotic system as a fusion protein.
    Ebrahimi SM; Tebianian M
    Mol Biol Rep; 2010 Jul; 37(6):2877-83. PubMed ID: 19813102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.